ICD-10-CM 2027 diagnosis code
T39.395Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID]
T39.395 is a header code, so it can't be reported by itself. Choose one of the 3 more specific codes beneath it and add the required 7th character.Short description: Adverse effect of other nonsteroidal anti-inflammatory drugs
Code unchanged since ICD-10-CM took effect on October 1, 2015. Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data
About T39.395
T39.395 is the ICD-10-CM diagnosis code for adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID]. It belongs to category T39 (poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics), block T36-T50 (poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances) and chapter 19 (injury, poisoning and certain other consequences of external causes). It is a header code, so it can't be reported by itself; one of its 3 subcodes must be used instead.
Within T39.39, choose T39.395 (Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID]) only when documentation doesn't support a more specific option: poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional) (T39.391), poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm (T39.392), poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault (T39.393), poisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined (T39.394) and underdosing of other nonsteroidal anti-inflammatory drugs [NSAID] (T39.396).
Codes in this range require a 7th character: A for initial encounter, D for subsequent encounter and S for sequela. Use placeholder "X" characters to fill any empty positions before the 7th character.
It has been part of ICD-10-CM since the code set took effect on October 1, 2015 and hasn't changed since.
7th character
The appropriate 7th character is to be added to each code from category T39
Notes that apply from higher levels
Instructions written at a parent level also apply to T39.395.
Table of Drugs & Neoplasms entries
- Anti-inflammatory drug NEC — Adverse effect
- Anti-inflammatory drug NEC › nonsteroidal NEC — Adverse effect
- Anti-inflammatory drug NEC › specified NEC — Adverse effect
- Diclofenac — Adverse effect
- Etodolac — Adverse effect
- Fenflumizole — Adverse effect
- Flufenamic acid — Adverse effect
- Indometacin — Adverse effect
- Indomethacin — Adverse effect
- Isoxicam — Adverse effect
- Meclofenamate — Adverse effect
- Meclofenamic acid — Adverse effect
- Mefenamic acid — Adverse effect
- Nabumetone — Adverse effect
- Nimesulide — Adverse effect
- Piroxicam — Adverse effect
- Proquazone — Adverse effect
- Sulindac — Adverse effect
- Tenoxicam — Adverse effect
- Tolmetin — Adverse effect
- Ufenamate — Adverse effect
- Zomepirac — Adverse effect
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
- No changes since FY2016.
Common questions about T39.395
Is T39.395 billable?
- No. T39.395 is a header code. Report one of its more specific subcodes instead.